• Topics

  • Formats

Organiser: CELforPharma

By Prof. Dr. Lieven Annemans

Pharma/medtech products cannot be successful without a favourable cost-effectiveness and budget impact profile.

Therefore, all managers in clinical development, regulatory, market access (and related), medical affairs and marketing should understand the fundamentals of health economic evaluations and budget impact analysis.

Only then will they take product-related decisions that consider the payers’ perspectives and optimally communicate value to payers, KOLs and other external stakeholders.

Upon completion of this course, you will master the fundamentals of health economic evaluations as a non-health-economist, and add value to decisions and communications related to products in R&D and/or brands in the market.

By participating, you will not only have the chance to ask your specific questions to a renowned expert, but also experience the unique opportunity to share experiences and engage in in-depth discussions with your international peers.

Available Dates

You are attempting to log out of MyMA

Do you really want to log out?